| Drugs with this side effect as MedDRA Preferred Term
			
			
	  	5-ASA
				
			Estrofem
				
			Glat copolymer
				
			ICI 182,780
				
			L-Dmp
				
			LY146032
				
				
					Vaginal moniliasis: 0% - 1.7% Meropenem anhydrous
				
			Oestrogen
				
				
					Vaginal moniliasis: uncommon, 4% - 8% TR-700
				
				
					Vulvovaginal mycotic infectionamoxicillin
				
				
					Vaginal moniliasisVulvovaginal mycotic infection: 1.99% - 2.61% aripiprazole
				
				
					Vaginal moniliasisVaginal mycosisaztreonam
				
			bupropion
				
			canagliflozin
				
				
					Vulvovaginal mycotic infectioncefaclor
				
			cefdinir
				
			cefditoren
				
			cefepime
				
			cefotetan
				
			cefoxitin
				
			ceftobiprole
				
				
					Vulvovaginal mycotic infectioncefuroxime
				
				
					Vaginal moniliasis: postmarketing cefuroxime axetil
				
			ciprofloxacin
				
				
					Vaginal moniliasis: postmarketing, 1% - 2% citalopram
				
				
					Vaginal moniliasis: infrequent, uncommon Vulvovaginal mycotic infection: infrequent clarithromycin
				
			clindamycin
				
				
					Vaginal moniliasis: 1.5% - 13.3% clindamycin phosphate
				
			conjugated estrogens
				
				
					Vaginal moniliasis: postmarketing, 0% - 1.4% copolymer 1
				
			dalbavancin
				
				
					Vulvovaginal mycotic infectiondapagliflozin
				
				
					Vulvovaginal mycotic infectiondelavirdine
				
			deprenyl
				
				
					Vaginal moniliasis: infrequent doxorubicin
				
			doxycycline
				
				
					Vaginal moniliasisVulvovaginal mycotic infection: 2.03% doxycycline hyclate
				
			empagliflozin
				
			ertapenem
				
			estradiol
				
				
					Vaginal moniliasis: postmarketing, 6.19% - 10.7% Vaginal mycosis: 0.82% - 6.4% Vulvovaginal mycotic infection: 8.29% estradiol cypionate
				
			estradiol valerate
				
			estrone
				
			fenofibrate
				
			fluticasone furoate
				
			fosphenytoin
				
				
					Vaginal moniliasis: infrequent gabapentin
				
				
					Vaginal moniliasis: infrequent lamotrigine
				
				
					Vaginal moniliasis: rare, infrequent lasofoxifene
				
			leflunomide
				
			levonorgestrel
				
			linezolid
				
				
					Vaginal moniliasis: 0.4% - 1.8% lomefloxacin
				
			medroxyprogesterone
				
			medroxyprogesterone acetate
				
			meropenem
				
			metronidazole
				
				
					Vaginal moniliasisVaginal mycosis: 0.18% - 1.06% moxifloxacin
				
				
					Vaginal moniliasisVulvovaginal mycotic infectionmycophenolate mofetil
				
			norfloxacin
				
				
					Vaginal moniliasis: postmarketing ofloxacin
				
				
					Vaginal moniliasis: postmarketing ogen
				
			paroxetine
				
				
					Vaginal moniliasis: rare, infrequent, 1% phenytoin
				
				
					Vaginal moniliasis: infrequent pilocarpine
				
			pramipexole
				
			pregabalin
				
				
					Vaginal moniliasis: infrequent progesterone
				
			quetiapine
				
				
					Vaginal moniliasis: infrequent rasagiline
				
				
					Vaginal moniliasis: infrequent riluzole
				
			ropinirole
				
				
					Vaginal moniliasis: infrequent Vaginal mycosis: infrequent salbutamol
				
			sitaxsentan
				
			sparfloxacin
				
				
					Vaginal moniliasis: postmarketing, 2.8% tacrolimus
				
			telithromycin
				
			tibolone
				
				
					Vaginal moniliasisVaginal mycosistigecycline
				
			tizanidine
				
				
					Vaginal moniliasis: infrequent  |